Trial Profile
Phase I Clinical Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- Sponsors Nanjing Sike Pharmaceutical
- 27 Apr 2009 New trial record